A. Ullrich

38.9k total citations · 13 hit papers
193 papers, 33.0k citations indexed

About

A. Ullrich is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, A. Ullrich has authored 193 papers receiving a total of 33.0k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Molecular Biology, 58 papers in Oncology and 57 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in A. Ullrich's work include Monoclonal and Polyclonal Antibodies Research (57 papers), HER2/EGFR in Cancer Research (44 papers) and Protein Kinase Regulation and GTPase Signaling (36 papers). A. Ullrich is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (57 papers), HER2/EGFR in Cancer Research (44 papers) and Protein Kinase Regulation and GTPase Signaling (36 papers). A. Ullrich collaborates with scholars based in Germany, United States and United Kingdom. A. Ullrich's co-authors include Joseph Schlessinger, Yosef Yarden, Reiner Lammers, Ben Margolis, Esther Zwick, Yosef Yarden, Teresa L. Yang‐Feng, Norbert Prenzel, Edward Y. Skolnik and Thomas J. Dull and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

A. Ullrich

192 papers receiving 31.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences

1984 2.1k citations Julian Downward, A. Ullrich et al. Nature profile →
Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.

1986 1.6k citations A. Ullrich et al. The EMBO Journal profile →
GROWTH FACTOR RECEPTOR TYROSINE KINASES

1988 1.6k citations Yosef Yarden, A. Ullrich Annual Review of Biochemistry profile →
The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling

1992 1.4k citations Ben Margolis, Reiner Lammers et al. profile →
Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

1987 1.4k citations Yosef Yarden, Thomas J. Dull et al. The EMBO Journal profile →
Growth factor signaling by receptor tyrosine kinases

1992 1.3k citations Joseph Schlessinger, A. Ullrich profile →
Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors

1986 1.1k citations Yosef Yarden, A. Ullrich et al. Nature profile →
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.

1999 885 citations A. Ullrich et al. PubMed profile →
EGF induces tyrosine phosphorylation of phospholipase C-II: A potential mechanism for EGF receptor signaling

1989 716 citations Ben Margolis, A. Ullrich et al. profile →
The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.

1993 628 citations E. Y. Skolnik, A. Ullrich et al. The EMBO Journal profile →
Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases

1991 582 citations Ben Margolis, Moosa Mohammadi et al. profile →
The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.

2001 553 citations A. Ullrich et al. profile →
Epidermal growth factor receptors: critical mediators of multiple receptor pathways

1999 509 citations A. Ullrich et al. profile →

Peers

Countries citing papers authored by A. Ullrich

Since Specialization

Citations

This map shows the geographic impact of A. Ullrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ullrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ullrich more than expected).

Fields of papers citing papers by A. Ullrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Ullrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ullrich. The network helps show where A. Ullrich may publish in the future.

Co-authorship network of co-authors of A. Ullrich

This figure shows the co-authorship network connecting the top 25 collaborators of A. Ullrich. A scholar is included among the top collaborators of A. Ullrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Ullrich. A. Ullrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel members of quinoline compound family enhance insulin secretion in RIN-5AH beta cells and in rat pancreatic islet microtissue 2017 ·Scientific Reports ·(unknown), (unknown), Ferenc Baska, István Szabadkai, Robert Torka, J. Hartmann, László Őrfi, A. Ullrich	7
2	Pharmacophore and Binding Analysis of Known and Novel B-RAF Kinase Inhibitors 2014 ·Current Medicinal Chemistry ·Ferenc Baska, István Szabadkai, (unknown), (unknown), Csaba Szántai-Kis, (unknown), Rita Garamvölgyi, Z. Nemes, Lars Neumann, Robert Torka, A. Ullrich, Gÿorgý Kéri, László Őrfi	10
3	Signal regulation by family conspiracy 2001 ·Cellular and Molecular Life Sciences ·Charles Cant, A. Ullrich	48
4	Mig-6 Is a Negative Regulator of the Epidermal Growth Factor Receptor Signal 2001 ·Biological Chemistry ·(unknown), Mikhail L. Gishizky, A. Ullrich	129
5	Insulin inhibits leptin receptor signalling in HEK293 cells at the level of janus kinase-2: a potential mechanism for hyperinsulinaemia-associated leptin resistance 2001 ·Diabetologia ·Monika Kellerer, Reiner Lammers, Andreas Fritsche, (unknown), Fausto Machicao, P. Borboni, A. Ullrich, Hans‐Ulrich Häring	37
6	Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases. 1998 ·PubMed ·Yoshiyuki Kubota, (unknown), Gerhard Niederfellner, Ronald Herbst, A. Ullrich	25
7	Protein kinase C isoforms α, δ and θ require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells) 1998 ·Diabetologia ·Monika Kellerer, Joanne Mushack, E. Seffer, Harald Mischak, A. Ullrich, Hans‐Ulrich Häring	91
8	Protein kinase C isoforms β 1 and β 2 inhibit the tyrosine kinase activity of the insulin receptor 1997 ·Diabetologia ·Birgit Bossenmaier, Luitgard Mosthaf, Harald Mischak, A. Ullrich, Hans‐Ulrich Häring	83
9	Interaction of the receptor tyrosine kinase p145^c‐kit with the p210^bcr/abl kinase in myeloid cells 1996 ·British Journal of Haematology ·Michael Hallek, S. Danhauser-Riedl, Ronald Herbst, Markus Warmuth, (unknown), (unknown), Brian Druker, J D Griffin, Bertold Emmerich, A. Ullrich	40
10	The receptor tyrosine kinase p185HER2 is expressed on a subset of B- lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia 1995 ·Blood ·Bühring Hj, I Sures, Bahija Jallal, (unknown), F.W. Busch, W-D Ludwig, Rupert Handgretinger, (unknown), A. Ullrich	34
11	The secreted tumor-associated antigen 90K is a potent immune stimulator 1994 ·Journal of Biological Chemistry ·A. Ullrich, I Sures, M. D'Egidio, Bahija Jallal, Timothy J. Powell, Ronald Herbst, (unknown), (unknown), Mark P. Rubinstein, Clara Natoli	173
12	Aggregation-induced activation of the epidermal growth factor receptor protein tyrosine kinase 1993 ·Biochemistry ·Moosa Mohammadi, Annemarie Honegger, Andrey Sorokin, A. Ullrich, Joseph Schlessinger, David R. Hurwitz	48
13	Interaction of Phosphatidylinositol 3-Kinase-Associated p85 with Epidermal Growth Factor and Platelet-Derived Growth Factor Receptors 1992 ·Molecular and Cellular Biology ·Patrick J Hu, Ben Margolis, E. Y. Skolnik, Reiner Lammers, A. Ullrich, Joseph Schlessinger	94
14	Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs 1992 ·Nature ·Ben Margolis, Patrick J Hu, Shulamit Katzav, (unknown), Janet M. Oliver, A. Ullrich, Arthur Weiss, Joseph Schlessinger	321
15	p185HER2 signal transduction in breast cancer cells 1991 ·Journal of Biological Chemistry ·G K Scott, (unknown), (unknown), R. M. Johnson, Jay Sarup, (unknown), A. Ullrich, H. Michael Shepard, Christopher C. Benz	83
16	Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth. 1991 ·Proceedings of the National Academy of Sciences ·Ilana Stancovski, Esther Hurwitz, O. Leitner, A. Ullrich, Yosef Yarden, Michael Sela	180
17	HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. 1989 ·The EMBO Journal ·(unknown), Thomas J. Dull, Irit Lax, Joseph Schlessinger, A. Ullrich	126
18	GROWTH FACTOR RECEPTOR TYROSINE KINASES breakdown → 1988 ·Annual Review of Biochemistry ·Yosef Yarden, A. Ullrich	1561
19	Molecular analysis of signal transduction by growth factors 1988 ·Biochemistry ·Yosef Yarden, A. Ullrich	178
20	The structure and function of the epidermal growth factor receptor studied by using antisynthetic peptide antibodies 1985 ·Proceedings of the Royal Society of London. Series B, Biological sciences ·William J. Gullick, Julian Downward, Peter J. Parker, Nigel Whittle, Richard Kris, Joseph Schlessinger, A. Ullrich, Michael D. Waterfield	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact